mRNA-Based Therapeutics Summit
Evvnt Promotion / evvnt
Archive
13.07.2021 - 15.07.2021 Virtual
Time: 8:30 am - 5:30 pm
Conference themes
2020 marked a landmark year for mRNA-Based Therapies, and the dramatic success of mRNA-based vaccines for emergency use against COVID-19 was a triumph for a previously unproven mRNA technology. Now, the landscape of successful treatments seems limitless, and the future looks bright for mRNA therapies. With this, we are excited to announce the official release of the inaugural mRNA Based Therapeutics Summit!
2020 marked a landmark year for mRNA-Based Therapies, and the dramatic success of mRNA-based vaccines for emergency use against COVID-19 was a triumph for a previously unproven mRNA technology. Now, the landscape of successful treatments seems limitless, and the future looks bright for mRNA therapies. With this, we are excited to announce the official release of the inaugural mRNA Based Therapeutics Summit!
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/748182-3?pid=4832
Speakers: Lori Panther, Vice President, Clinical Development, Infectious Diseases, Moderna, Inc, Jacob Becraft, Chief Scientific Officer and Co-Founder, Strand Therapeutics Inc and more
Brochure: https://go.evvnt.com/748182-3?pid=4832
Speakers: Lori Panther, Vice President, Clinical Development, Infectious Diseases, Moderna, Inc, Jacob Becraft, Chief Scientific Officer and Co-Founder, Strand Therapeutics Inc and more
Enquiries and Registration:
https://go.evvnt.com/748182-1?pid=4832
Mr. Customer Service
General Medicine
Languages
English
English
Congress fees
Conference Only: USD 1999.00, Conference + Delivery and Manufacturing Focus Day: USD 2797.00
Conference Only: USD 1999.00, Conference + Delivery and Manufacturing Focus Day: USD 2797.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
